Abstract
Sudden Cardiac Death resulting from sustained ventricular fibrillation or malignant cardiac arrhythmia has been linked to the type of dietary fat intake in several economically well developed countries where high levels of saturated fatty acids are common. Experimental studies with the small non-human primate marmoset monkey have clearly demonstrated the health benefit of substituting polyunsaturated fatty acids (PUFA's) for dietary saturated fatty acids. Heart rate and blood pressure are lowered, while the left ventricular ejection fraction and the electrical threshold for the induction of ventricular fibrillation are both increased after prolonged feeding of PUFA enriched diets. All these changes in heart function reduce the risk of developing malignant cardiac arrhythmias.
The fatty acid composition of cardiac membrane phospholipids is profoundly altered by these changes in dietary lipid intake. In particular the proportions of arachidonic acid (AA), eicosapentaenoic acid (EPA) and docosahexae noic acid (DHA) are altered in such a way that the production of myocardial eicosanoids is affected. Although the changes in proportion of these long-chain PUFA's in cardiac phosphatidyl ethanolamine and phosphatidyl inositol are not identical, the shift in balance between these substrates or inhibitors of cyclo-oxygenase activity leads to relatively greater production of prostacyclin (PGI2) than thromboxane (TXA2).
The effect of the omega-3 PUFA's of fish oil is proportionally greater than that of linoleic acid (LA; 18:2, ω6) rich sunflower seed oil, particularly during ischaemia, and probably reflects the different nutritionally induced changes in cardiac membrane fatty acid composition by these different types of dietary PUFA's. (Mol Cell Biochem 116: 19–25, 1992).
Similar content being viewed by others
References
Lown B: Sudden Cardiac Death: The major challenge confronting contemporary cardiology. Am J Cardiol 43: 313–328, 1979
Keefe DL, Schwartz J, Somberg JC: The substrate and the trigger: The role of myocardial vulnerability in sudden cardiac death. Am Heart J 113: 218–225, 1987
Myerberg RJ, Kessler KM, Bassett AL, Castellanos A: A biological approach to Sudden Cardiac Death: Structure, Function and Cause. Am J Cardiol 63: 1512–1516, 1989
Anderson JL: Sudden Cardiac Death, Ventricular Arrhythmias and Antiarrhythmic Therapy. Aust NZJ Med 16: 409–412, 1986
Echt DS, Liebson PR, Michell BR, Peters RW: et al. CAST investigators. Mortality and morbidity in patients receiving Encainide, Flecainide or Placebo: The Cardiac Arrhythmia Suppression Trial. New Engl J Med 324: 781–788, 1991
Goldstein RE, Boccuzzi SJ, Cruess Det al.: Diltiazein increases late-onset congestive heart failure in post-infarction patients with early reduction in ejection fraction. Circulation 83: 52–60, 1991
Charnock JS, McIntosh GH, Abeywardena MY, Russell GR: Changes in fatty acid composition of the cardiac phospholipids of the cotton-eared marmoset after feeding different lipid supplements. Ann Nutr Metab 29: 83–95, 1985
Charnock JS, Abeywardena MY, McLennan PL: Tissue specific differences in the fatty acid composition of the marmoset monkey. Comp Biochem Physiol 92A: 299–304, 1989
McLennan PL, Abeywardena MY, Charnock JS: The influence of age and dietary fat in an animal model of Sudden Cardiac Death. Aust NZ J Med 19: 1–5, 1989
McLennan PL, Abeywardena MY, Charnock JS: Reversal of the arrhythmogenic effects of long-term saturated fatty acid intake by dietary n-3 and n-6 polyunsaturated fatty acids. Am J Clin Nutr 51: 53–59, 1990
McLennan PL, Abeywardena MY, Charnock JS: Dietary fish oil prevents ventricular fibrillation following occlusion and reperfusion. Am Heart J 116: 709–711, 1988
Kromhout D, Bosschieter EB, Coulander C de L: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. New Engl J Med 312: 1205–1209, 1985
Burr ML, Fehily AM, Gilbert JF, Rogers Set al.: Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction. Diet and Reinfarction Trial (DART). Lancet ii, 757–761,1989
Pitt B: Sudden Cardiac Death: Role of left ventricular dysfunction. Ann N.Y. Acad Sci 382: 218–222, 1983
Lesch M, Kehoe RF: Predicability of Sudden Cardiac Death. New Engl J Med 310: 255–257, 1984
Charnock JS, Abeywardena MY, McLennan PL: Dietary lipids, membrane composition and cardiac function. Colloque INSERM 195: 135–144, 1989
Hetzel BS, Charnock JS: Aging and the heart. In: DM Prinsley and HH Sandstead (eds.) Nutrition and Aging. Alan R Liss Inc New York 1990, pp 21–37
McLennan PL, Abeywardena MY, Charnock JS, McMurchie EJ: Dietary lipid modulation of myocardial β-adrenergic mechanisms, Ca2+-dependent automaticity and arrhythmogenesis in the marmoset. J Cardiovasc Pharmacol 10: 293–300, 1987
Abeywardena MY, Fischer S, Schweer H, Charnock JS: In vivo formation of metabolites of prostaglandin I2 and 13 in the marmoset monkey (Callithrix jacchus) following dietary supplementation with tuna fish oil. Biophys Acta 1003: 161–166, 1989
McIntosh GH, Barnden LR, Buttfield IH, Charnock JS: Gated blood pool studies of cardiac function in the rat and marmoset. J Nucl Med 24: 728–731, 1983
Charnock JS, McLennan PL, McIntosh GH, Barnden LR, Buttfield IH: Radionuclide angiographic study of the influence of dietary lipid supplements on cardiac function in the marmoset. Cardiovasc Res 21: 369–376, 1987
McLennan PL, Bridle TM, Abeywardena MY, Charnock JS: Dietary lipid modification of ventricular fibrillation threshold in the marmoset monkey. J Mol Cell Cardiol 22: p viii (Abstract # 23) 1990
Abeywardena MY, McLennan PL, Charnock JS: Effects of variable lineolate intake on aortic PGI2-like activity and fatty acid composition: Differences between the rat and marmoset monkey. Prostaglandins Leukotrienes and Med 25: 209–221, 1986
Abeywardena MY, McLennan PL, Charnock JS: Differential effects of dietary fish oil on myocardial prostaglandin I2 and thromboxane A2 production. Am J Physiol 260: H379–385, 1991
Charnock JS, Abeywardena MY, Poletti VM, McLennan PL: Differences in fatty acid composition of various tissues of the marmoset monkey after different lipid supplemented diets. Comp Biochem Physiol 101A: 387–393, 1992
Hokin LE: Receptors and phosphoinositide-generated second messengers. Ann Rev Biochem 54: 205–235, 1985
Chap H, Simon MF, Plantavid M, Mauco G, Flauvel and DousteBlazy L: Platelet Phosphoinositides. Colloque INSERM 152: 21–32, 1987
Parratt JR, Wainwright CL, Coker SJ, Zeitlin IJ: Eicosanoids and cardiac arrhythmia. Biomed Biochim Acta 47: 813–818,1988
Burr ML, Fehily AM: Fatty fish and heart disease: A randomized controlled trial. In Health Effects of ω3 Polyunsaturated Fatty Acids in Seafoods. World Rev Nutr Diet 66: 306–312, 1991
Dreizen S, Levy BM, Bernick S: Diet-induced atherosclerosis in the marmoset. Proc Soc Exptl Biol Med 143: 1218–1223, 1973
Abbey M, Clifton PM, McMurchie EJ, McIntosh GH, Nestel PJ: The effect of a high fat/cholesterol diet with or without eicosapentaenoic acid on plasma lipids, lipoproteins and lipid transfer activity in the marmoset. Atheroscleros 81: 163–174, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Charnock, J.S., McLennan, P.L. & Abeywardena, M.Y. Dietary modulation of lipid metabolism and mechanical performance of the heart. Mol Cell Biochem 116, 19–25 (1992). https://doi.org/10.1007/BF01270564
Issue Date:
DOI: https://doi.org/10.1007/BF01270564